IsraelOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1,011 out of 61,090 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 165,702 | 159,745 |
| Total Cites | 4,524 | 5,043 |
| H-index | 36 | 37 |
| Hm-index | 13 | 15 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 60 | 85 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 646 | 752 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 3,060 | 3,414 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,676 | 2,792 |
| Ratio of Total Citations to Distinct Citing Papers | 1.69 | 1.81 |
| Self-Citation Percentage |
10.29%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 963 out of 57,585 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 158,099 | 156,047 |
| Total Cites | 4,336 | 4,853 |
| H-index | 36 | 36 |
| Hm-index | 13 | 15 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 57 | 82 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 611 | 716 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 2,933 | 3,285 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,544 | 2,660 |
| Ratio of Total Citations to Distinct Citing Papers | 1.70 | 1.82 |
| Self-Citation Percentage |
10.65%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 974 out of 54,095 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 158,274 | 149,001 |
| Total Cites | 4,143 | 4,661 |
| H-index | 34 | 36 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 54 | 79 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 573 | 678 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 2,790 | 3,143 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,426 | 2,542 |
| Ratio of Total Citations to Distinct Citing Papers | 1.71 | 1.83 |
| Self-Citation Percentage |
11.11%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 950 out of 51,411 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 152,347 | 147,779 |
| Total Cites | 3,927 | 4,432 |
| H-index | 34 | 36 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 47 | 70 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 536 | 637 |
| Number of Single+First+Last Authored Papers | 65 | 65 |
| Total Cites to Single+First+Last Authored Papers | 2,644 | 2,986 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,275 | 2,390 |
| Ratio of Total Citations to Distinct Citing Papers | 1.73 | 1.85 |
| Self-Citation Percentage |
11.39%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 907 out of 49,699 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 145,334 | 140,752 |
| Total Cites | 3,834 | 4,327 |
| H-index | 34 | 36 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 47 | 69 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 522 | 620 |
| Number of Single+First+Last Authored Papers | 65 | 65 |
| Total Cites to Single+First+Last Authored Papers | 2,573 | 2,906 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,217 | 2,332 |
| Ratio of Total Citations to Distinct Citing Papers | 1.73 | 1.86 |
| Self-Citation Percentage |
11.39%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 883 out of 41,196 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 138,978 | 130,385 |
| Total Cites | 3,531 | 4,018 |
| H-index | 33 | 36 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 45 | 66 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 480 | 576 |
| Number of Single+First+Last Authored Papers | 64 | 64 |
| Total Cites to Single+First+Last Authored Papers | 2,365 | 2,690 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,041 | 2,155 |
| Ratio of Total Citations to Distinct Citing Papers | 1.73 | 1.86 |
| Self-Citation Percentage |
12.12%
|
|
Related Profiles
Top 2% Scientists by Country
236,132 scientists from 167 countries on the 2025 single-year list.
Israel1,637 scientists, 21st in the world
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.